Galectin Therapeutics Inc. (GALT)
NCM · Common · CUSIP 363225202
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GALT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
363225202
Market Cap
Small Cap
Business: Galectin Therapeutics Inc. is a biotechnology company focused on discovery and development. The Company applies our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer.

Company Contact

CEO
Joel Lewis
CFO
Jack W. Callicutt
Headquarters
4960 Peachtree Industrial Blvd., Suite 240, Norcross, GA 30071
Phone
678-620-3186
Fax
770-864-1327
Investor Relations
Jack Callicutt · 678-620-3186 · ir@galectintherapeutics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »